CNDSN3 month 5 days [] (Jin Shili Jiayou) in March 4, 2015, the National People's Congress, Tasly Group Holdings Limited chairman of the board Yan Xijun guest xinhuanet.com, talk about modern Chinese medicine and health industry internationalization. The graph is et al. Dept.of high altitude disease friend answerquestions.

Deputies to the National People's Congress, Tasly Holdings Group chairman of the board of directors Yan Xijun visit today interview with Xinhua, xinhuanet.com netizens online exchanges this year he NPC and CPPCC suggestions. Yan Xijun said, is proposed to shorten the approval time drug improvement, also set up the third party drug approval platform socialization.

Yan Xijun think, now already through the national approval of new drugs and drug, in the development process, according to the demand of the market, will carry out some technical improvements, do not need to follow the process to go so long time. So, to have marketed drugs, to perfect the standard system or supplement the needs of the market, increased the number of supplementary application, should be established "Easy Access", not in accordance with the practice of the process takes a long time. After thisalso can make the drug market, timely detection of problems, timely supplement, promptly improve, so that consumers on the safe and effective use of drug.

Yan Xijun said, affected by the preparation and financial, human and technical resources of drug approval is far from enough, bill is more and more, the current backlog of nearly 30000 drug application materials. Last year he also called for a national increase in compilation and investment. He suggested that the drug approval to open markets, establish a socialized third party approval platform. *

(original title: the et al. Dept.of high altitude disease guest xinhuanet.com suggested that third party drug approval platform)

Editor: Blue